<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03567928</url>
  </required_header>
  <id_info>
    <org_study_id>43/int/2018</org_study_id>
    <nct_id>NCT03567928</nct_id>
  </id_info>
  <brief_title>Laryngeal Mask in Upper Gastrointestinal Procedures</brief_title>
  <acronym>SeoMask</acronym>
  <official_title>Anesthesiological Management of Ventilation With Laryngeal Mask in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale San Raffaele</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diagnostic and operative procedures of upper gastrointestinal (GI) tract are very common in
      all patients. Some procedures are difficult to tolerate because of long duration, prone
      position or significant stimulation of the upper airways. An example are endoscopic
      retrograde cholangiopancreatography (ERCP) and endoscopic pancreatic ultrasound.

      The procedures are generally performed with deep sedation. Many pharmacologic regimens are
      available and described in literature. The investigator's institute adopts propofol target
      controlled infusion (TCI), which usually guarantees unconsciousness and unresponsiveness of
      patients. The main adverse event is dose-related respiratory depression. Pre-existing reasons
      for hypoventilation can exacerbate this event, especially in the elderly and the chronic
      obstructive pulmonary disease-patients. Laryngeal mask (LMA) is a useful tool to apply a
      pressure support ventilation. One specific type of LMA allows to separate the gastric and
      respiratory tract and, allows the anesthesiologist to support patient's ventilation as (and
      only if) necessary.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a monocentric randomized controlled trial of superiority of LMA use in GI endoscopic
      procedures. Randomization is centralized. The study is single blind (patient). The study is
      no-profit. Every patients undergoing scheduled ERCP and endoscopic ultrasound will be
      screened and consecutive eligible patients will be enrolled. Subjects will be allocated
      according to a simple randomization list. The study starts after randomization and ends after
      discharge from the recovery room. After peripheral venous catheter insertion and vital
      parameters monitoring, patients will receive propofol TCI with a tailored target between 4
      and 6 mcg/ml. The treatment group will receive LMA insertion and End-Tidal Carbon Dioxide
      (ETCO2) monitoring throughout the procedure. In case of hypoventilation, with an ETCO2 above
      50 mmHg, the patient will be supported as necessary with PSV. The control group will not
      receive any airway device, according to the standard treatment. At the end of the procedure,
      both group will receive a laboratory testing (peripheral arterial sample), when the patient
      is still sedated. Vital parameters monitoring will continue in recovery room. Patients will
      be discharge as usual with an Aldrete score &gt; 9.

      Data will be collected during the procedure and in recovery room. Data will be stored in
      electronic database without mention to patient's name.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Technical problem with device in study
  </why_stopped>
  <start_date type="Actual">September 26, 2018</start_date>
  <completion_date type="Actual">April 10, 2019</completion_date>
  <primary_completion_date type="Actual">April 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two groups: one receive sedation in spontaneous breathe, the other receive sedation with laryngeal mask</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Induction of anesthesia and subsequent use (or not) of the device (laryngeal mask)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Partial Pressure of Carbon Dioxide (PaCO2)</measure>
    <time_frame>Just before patient awakening (approximately 90-120 min after induction of anesthesia)</time_frame>
    <description>PaCO2 level assessed by arterial sample</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of pressure support ventilation in treatment group</measure>
    <time_frame>During the procedure</time_frame>
    <description>Number needing pressure support ventilation (PSV) in the treatment group. A PSV will be performed in case of End-Tidal carbon dioxide level raising above 50 mmHg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pH</measure>
    <time_frame>Just before patient awakening (approximately 90-120 min after induction of anesthesia)</time_frame>
    <description>pH assessed by arterial sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial Pressure of Oxygen (PaO2)</measure>
    <time_frame>Just before patient awakening (approximately 90-120 min after induction of anesthesia)</time_frame>
    <description>PaO2 level assessed by arterial sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to recover after the procedure</measure>
    <time_frame>During recovery room stay (approximately 15-45 min after patient awakening)</time_frame>
    <description>Time needed to recover: from arrival in recovery room to a Aldrete Score &gt; 9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of the procedure operator</measure>
    <time_frame>1 minute after patient awakening</time_frame>
    <description>Satisfaction of the operator assessed by a Likert 5 points-scale: 1 &quot;Strongly disagree&quot;; 2 &quot;Disagree&quot;; 3 &quot; Neutral/Neither agree nor disagree&quot;; 4 &quot;Agree&quot;; 5 &quot;Strongly agree&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of the patient</measure>
    <time_frame>20 minutes after patient awakening</time_frame>
    <description>Satisfaction of the patient assessed by a Likert 5 points-scale: 1 &quot;Strongly disagree&quot;; 2 &quot;Disagree&quot;; 3 &quot; Neutral/Neither agree nor disagree&quot;; 4 &quot;Agree&quot;; 5 &quot;Strongly agree&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of completed endoscopic procedures</measure>
    <time_frame>During the procedure</time_frame>
    <description>Number of completed endoscopic procedures without necessity to change anesthesiological treatment or postpone the procedure for any reason</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Anesthesia</condition>
  <condition>Airway Device</condition>
  <condition>C.Surgical Procedure; Gastrointestinal</condition>
  <arm_group>
    <arm_group_label>Standard Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Treatment Sedation with propofol target controlled infusion (TCI) and no airway devices (mandatory spontaneous breathe)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interventional Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interventional Treatment Sedation with propofol target controlled infusion (TCI) and Gastro Cuff Pilot Laryngeal Mask (possibility to use a pressure-support ventilation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sedation with Gastro Cuff Pilot Laryngeal Mask</intervention_name>
    <description>This specific type of laryngeal mask allows to separate the gastric and respiratory tract and allows the anesthesiologist to support patient's ventilation as (and only if) necessary.</description>
    <arm_group_label>Interventional Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Target controlled infusion (TCI) with propofol</description>
    <arm_group_label>Interventional Treatment</arm_group_label>
    <arm_group_label>Standard Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;18 years

          -  written informed consent

          -  elective ERCP and endoscopic ultrasound procedure

        Exclusion Criteria:

          -  pregnancy

          -  contraindication to propofol administration

          -  contraindication to mask insertion (e.g. malformation)

          -  emergency operation (not scheduled)

          -  preexisting causes of hypoventilation (e.g. chronic obstructive pulmonary disease,
             neuromuscular diseaseâ€¦)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Massimo Agostoni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale San Raffaele</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <state>Milano</state>
        <zip>20131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 17, 2018</study_first_submitted>
  <study_first_submitted_qc>June 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2018</study_first_posted>
  <last_update_submitted>April 11, 2019</last_update_submitted>
  <last_update_submitted_qc>April 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale San Raffaele</investigator_affiliation>
    <investigator_full_name>Agostoni Massimo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 28, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT03567928/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

